ArticlePDF Available

Disability Work among Argentinean Patients with Rheumatoid Arthritis

Authors:
  • Hospital Bernardino Rivadavia

Abstract and Figures

Objective: 1) To analyze the prevalence of Work Disability (WD) in RA Argentinian patients who are attending at the National Rehabilitation Service (NRS); 2) To measure general, socioeconomics and disease characteristics in this popu-lation; 3) To characterize the associated factors of work disability in this group. Methods: Design cross section obser-vational study. RA patients attending the NRS were included in consecutive form. Clinical, demographic and radio-logical data were collected. All patients answered about their employment status. WD was defined if the work status was unemployed due to RA, retirement prior to the normal age, or disabled pension. Comparing analysis among pa-tients with and without paid work was done. Housewives, retired patients and students were excluded from the compar-ing analysis. Results: Three hundred and eleven patients were included (n = 311). The prevalence of WD was 44.05% (n = 137). During the study 85 (27.3%) patients were in paid employment, 48 (15.3%) were retired, 39 (12.5%) were housewives, and 2 (0.6%) patients were students. Factor associated to WD were female sex, more than 5 years of dis-ease duration, have health insurance, education beyond high school, and greater functional limitation: HAQ > 1 and function class 3 -4. In the multivariable logistic regression model female sex was a significant and independent predic-tor of WD. Having health insurance; and more than high school education were protector factors of WD in this model. Conclusion: WD prevalence in this sample was higher than other countries. Socioeconomics factors more than diseases factors were significant predictors of productivity loss in this sample.
Content may be subject to copyright.
Open Journal of Rheumatology and Autoimmune Diseases, 2012, 2, 73-76
doi:10.4236/ojra.2012.23014 Published Online August 2012 (http://www.SciRP.org/journal/ojra) 73
Disability Work among Argentinean Patients with
Rheumatoid Arthritis
Tamborenea Maria Natalia, Silvia Moyano Caturelli, Jackeline Spengler, Grisel Olivera Roulet
Servicio Nacional de Rehabilitación (SNR), Buenos Aires, Argentina.
Email: nataliatamborenea@hotmail.com
Received March 20th, 2012; revised April 27th, 2012; accepted May 9th, 2012
ABSTRACT
Objective: 1) To analyze the prevalence of Work Disability (WD) in RA Argentinian patients who are attending at the
National Rehabilitation Service (NRS); 2) To measure general, socioeconomics and disease characteristics in this popu-
lation; 3) To characterize the associated factors of work disability in this group. Methods: Design cross section obser-
vational study. RA patients attending the NRS were included in consecutive form. Clinical, demographic and radio-
logical data were collected. All patients answered about their employment status. WD was defined if the work status
was unemployed due to RA, retirement prior to the normal age, or disabled pension. Comparing analysis among pa-
tients with and without paid work was done. Housewives, retired patients and students were excluded from the compar-
ing analysis. Results: Three hundred and eleven patients were included (n = 311). The prevalence of WD was 44.05%
(n = 137). During the study 85 (27.3%) patients were in paid employment, 48 (15.3%) were retired, 39 (12.5%) were
housewives, and 2 (0.6%) patients were students. Factor associated to WD were female sex, more than 5 years of dis-
ease duration, have health insurance, education beyond high school, and greater functional limitation: HAQ > 1 and
function class 3 - 4. In the multivariable logistic regression model female sex was a significant and independent predic-
tor of WD. Having health insurance; and more than high school education were protector factors of WD in this model.
Conclusion: WD prevalence in this sample was higher than other countries. Socioeconomics factors more than diseases
factors were significant predictors of productivity loss in this sample.
Keywords: HAQ; Work Disability; Rheumatoid Arthritis
1. Introduction
Rheumatoid Arthritis is a chronic disabling condition that
may affect the lives of individual patients in many ways.
One of most important outcomes may be work disability
[1,2].
Participation in paid employment is a major life role
for most adults. People with arthritis can expect to be
employed fewer years than the general population [3,4]
and withdrawal from paid employment, or work disabil-
ity, is a relatively common outcome of RA. It results in
lost income for the patient and less productivity for soci-
ety [5].
Research into WD has been reported from USA and
from European countries, rates of this outcome reported
range from 22% to 85% [6].
Variations in estimated rates are likely due to differ-
ences in methods, subject selection, time, available treat-
ments and definitions of work disability.
National Rehabilitation Service (NRS) in Argentina,
evaluate patients with Rheumatoid Arthritis diagnosis
who request Disability Certification according to 22431
law. This law establishes the conditions for grant the
disability certificate. It is a public document issued by an
interdisciplinary team that performs a biopsychosocial
evaluation.
The National Disability Certificate is the admission
key to the health system and the principal tool for the
access to complete coverage of medication and rehabili-
tation.
In this study we analyze the prevalence of WD in RA
patients who are attending at the National Rehabilitation
Service (NRS) in Argentina and determine the associated
factors to this outcome in this group.
2. Patients and Methods
RA patients are attending at the NRS for tramit the Na-
tional Disability Certificate. They ask for this certificate
in voluntary way and the population are from Buenos
Aires province and rest of the all country.
From May 2008 to August 2008 RA patients were in-
cluded in consecutive form in this cross section observa-
tional study.
Copyright © 2012 SciRes. OJRA
Disability Work among Argentinean Patients with Rheumatoid Arthritis
74
Clinical, demographic and radiological data were col-
lected.
All patients answered about their employment status.
The first question asked “main form of work” was un-
employed, paid work, retired, housework, student or dis-
abled.
WD was defined if the work status were unemployed
due to RA, retirement prior to the normal age or disabled
pension.
We analyzed the following characteristics about the
disease: time of disease evolution, rheumatoid factor,
functional class, radiographic erosions, HAQ-A and DAS
28 results.
For assess the association among disease characteris-
tics and work status, were excluded for the analysis
housework, students and retired patients.
3. Statistical Analysis
The sample was characterized using descriptive proce-
dures.
To analyze categorical variables X2 were used and
Student’s t-test and Mann-Whitney test for continuous
variables.
The main analysis was multivariable logistic regres-
sion to assess the roles of independent variables as pre-
dictors of work disability.
The logistic regression model was constructed with the
following independent variables sex, education level,
health insurance, years of disease evolution, functional
class, anatomic class, HAQ-A and DAS28 results. We
calculated odds ratios and 95 % CIs. p values < 0.05 was
considered significant.
4. Results
Three hundred and eleven patients were included (n =
311). The prevalence of WD was 44. 05% (n = 137).
Women were 87% (n = 271) of the patients, the sam-
ple was predominantly middle aged (mean age 54 years),
the median time of disease evolution was 8 (4 - 15) years.
Around 75.8% (n = 236) had some type of health insur-
ance.
The 68.8% (n = 214) of the sample have education
beyond high school.
The HAQ-A score was bigger than 1 in 82.2% (n =
256) of the patients and the DAS28 was more than 3.2 in
the 83.3% (n = 259) of the sample. Function class was 3
or 4 in 199 patients (64.2%) and radiographies erosions
were present in 234 (76%) patients. 91% (n = 285) of the
population was positive for rheumatoid factor test (Table
1).
During the study 85 (27.3%) patients were in paid em-
ployment, 48 (15.3%) were retired, 39 (12.5%) were
housewives, and 2 (0.6%) patients were students (Table
1).
In the comparing analysis among patients with and
without paid work, were excluded housewives, retired
patients and students. To avoid expected retirement-re-
lated work cessation, subjects in our analysis were lower
than 65 years old, remaining 223 patients for this analy-
sis.
There were statistical significant differences when
comparing characteristics among patients with and with-
out WD, included gender (p: 0.001), more than 5 years of
disease duration (p: 0.013), have health insurance (p:
0.005), education beyond high school (p: 0.000), and
greater functional limitation: HAQ-A > 1 (p: 0.017) and
function class 3 - 4 (p: 0.026) (Table 2).
In the multivariable logistic regression model female
gender was a significant and independent predictor of
WD p: 0.004 OR IC 95% 3.2 (1.46 - 7.01). Having health
insurance p: 0.01 OR IC 95% 0.42 (0.21 - 0.81); and
more than high school education p: 0.000 IC 95% 0.25
(0.13 - 0.46) were protectors factors of WD in this model
(Table 3).
Table 1. Sample characteristics of subjects (n = 311).
Women n (%) 271 (87)
Age, mean (range) 54 (25 - 77)
Disease duration, median (IQR) 8 (4 - 15)
Health insurance n (%) 236 (75.8)
< High school education n (%) 214 (68.8)
Paid work n (%) 85 (27.3)
Retired n (%) 48 (15.3)
Housework n (%) 39 (12.5)
Students n (%) 2 (0.6)
Unemployed due to RA n (%) 111 (35.7)
Disabled pension n (%) 26 (8.5)
Rheumatoid factor + n (%) 285 (91.6)
Function classes 3 and 4 n (%) 199 (64.2)
Radiographic erosions n (%) 234 (76)
HAQ > 1 n (%) 256 (82.3)
DAS28 > 3.2 n (%) 259 (83.3)
Copyright © 2012 SciRes. OJRA
Disability Work among Argentinean Patients with Rheumatoid Arthritis
Copyright © 2012 SciRes. OJRA
75
Table 2. Comparative analysis among patients with and without paid work (n = 223).
WD n: 137 No WD n: 86 p OR 95% CI
Women % 90% (124/137) 74% (64/86) 0.001 3.2 1.5 - 6.93
Disease duration > 5 years 65.6% (90/137) 48.8% (42/86) 0.013 2 1.1 - 3.6
Health insurance 56.9% (78/137) 75.5% (65/86) 0.005 0.4 0.2 - 0.8
RF + % 92.7% (127/137) 95% (82/86) 0.42 0.61 0.1 - 2.2
High school 22.6% (31/137) 54.6% (47/86) 0.000 0.24 0.1 - 0.4
Radigraphic erosions 77% (106/137) 68.6% (59/86) 0.146 1.5 0.8 - 2.9
Function classes 3 - 4 71.5% (98/137) 56.9% (49/86) 0.026 1.89 1 - 3.4
HAQ > 1 79.5% (109/137) 65% (56/86) 0.017 2.08 1 - 4
DAS28 > 3.2 86.8% (119/137) 80% (69/86) 0.185 1.6 0.7 - 3.5
Table 3. Multivariable logistic regression model. Patients
with and without paid work (n = 223).
Variable OR 95% CI p
Women % 3.2 (1.46 - 7.01) 0.004
Disease duration > 5 years 1.78 (0.93 - 3.4) 0.08
Health insurance 0.42 (0.21 - 0.81) 0.01
High school 0.25 (0.13 - 0.46) 0.000
HAQ > 1 1.81 (0.88 - 3.71) 0.1
Function classes 3 - 4 1.3 (0.64 - 2.68) 0.45
5. Discussion
The loss of productivity associated with RA disability
places significant burden on patients, their families and
society as a whole [7].
Work disability is defined in this article as work cessa-
tion due to RA, retirement prior to the normal age, or
disability pension due to RA.
Rates of WD reported from USA and European coun-
tries range from 22% to 85% [6]. Recently Allaire et al.
reported that 35.1% of RA patients in US were work dis-
abled [8].
In this sample of RA Argentinean patients had the
prevalence of WD was 44.05%, higher than the last re-
ports from other countries. Employment status was de-
fined for us like Allaire’s study [8].
We found high prevalence of female gender, mean age
of 54 years old, mean disease duration of 8 years, and
high scores in DAS28 and HAQ.
Education level previous of RA diagnosis was low,
and lower than others population.
Factors associated with WD in this group were female
gender, absence of medical care, more than 5 years of
disease duration, low education level, worse functional
class and high HAQ score (Table 2).
Several studies agreed that medical care and education
status are important socioeconomics predictors of work
loss. In the same form, functional class and HAQ are
predictors related to the disease [9-11].
We didn’t find association between radiographic da-
mage and disability in this group. Recent studies have
demonstrated weak relationships between damage and
disability in the first 10 years of disease course. It ap-
pears that inflammation contributes much more to the
level of disability during the first years of disease course,
whereas radiographic progression contributes more stron-
gly after about 10 years of disease duration [12]. In our
study patients had 8 years of disease duration approxi-
mately and high score of DAS28.
In the multivariable analysis were significant and in-
dependent predictors of WD female gender, absence of
medical plan and education below high school.
Female gender has been reported to be an independent
risk factor for WD in RA in several studies. RA more
frequently starts early in females indicating that females
are exposed to the inflammation longer than males [13].
M. Wallenius et al. [14] found fourfold increased risk
in females, and reported differences in pain perceptions
and worse mental health among genders could contribute
to this point.
Health insurance absence in our country is associated
Disability Work among Argentinean Patients with Rheumatoid Arthritis
76
to difficulties in access to the medical system, delay to
start specific treatment and less possibilities to obtain the
new available drugs. It results in worse disease evolution
and disability increase.
Fewer years of schooling often result in a physically
demanding occupation with fewer possibilities for voca-
tional rehabilitation [15].
The HAQ disability has been a correlate of permanent
work disability in almost all studies [16-18]. In this sam-
ple HAQ wasn’t a significant independent predictor of
WD. However, this is a cross section study and HAQ
score was measured at the moment of processing disabil-
ity certificate, and not in the moment that the patient de-
veloped work loss.
There are several limitations in our study. Patients who
ask for disability certificate have probably more severs
forms of the disease, and in this point our results can be
overestimated. Sample size of 311 patients does not
allow extrapolating the results to all patients with Rheu-
matoid Arthritis in our country. In this study was not
recorded the type of patient’s work. Due to the study
design, we can not establish a temporal relationship be-
tween disability and work loss.
In conclusion, our data suggest that work disability
among persons with RA in Argentina is still a substantial
problem. We need design prospective cohort studies to
estimate the prevalence of WD in this country and iden-
tify the real impact of RA on paid work.
REFERENCES
[1] D. L. Scott and S. Steer, “The Course of Established
Rheumatoid Arthritis,” Best Practice & Research Clinical
Rheumatology, Vol. 21, No. 5, 2007, pp. 943-967.
doi:10.1016/j.berh.2007.05.006
[2] Saralynn and H. A. ScD, “Update on Work Disability in
Rheumatic Diseases,” Current Opinion in Rheumatology,
Vol. 13, No. 2, 2001, pp. 93-98.
doi:10.1097/00002281-200103000-00001
[3] K. Puolakka, H. Kautiainen, et al., “Monetary Value of
Lost Productivity over a Five-Year Follow Up in Early
Rheumatoid Arthritis Estimated on the Basis of Official
Register Data on Patients’ Sickness Absence and Gross
Income: Experience from the FIN-RACo Trial,” Annals
of the Rheumatic Diseases, Vol. 65, No. 7, 2006, pp.
899-904. doi:10.1136/ard.2005.045807
[4] A. Joung, J. Dixey, et al., “How Does Functional Disabil-
ity in Early Rheumatoid Arthritis Affect Patients and
Their Lives? Results from 5 Years of Follow-Up in 732
Patients from the Early RA Study,” Rheumatology, Vol.
39, No. 6, 2000, pp. 603-611.
doi:10.1093/rheumatology/39.6.603
[5] A.-C. Rat and M.-C. Boissier, “Rheumatoid Arthritis: Di-
rect and Indirect Costs,” Joint Bone Spine, Vol. 71, No. 6,
2004, pp. 518-524. doi:10.1016/j.jbspin.2004.01.003
[6] E. M. Barret, D. G. Scott, et al., “The Impact of Rheuma-
toid Arthritis on Employment Status in the Early Years of
Desease: A UK Community Based Study,” Rheumatology,
Vol. 39, No. 12, 2000, pp. 1403-1409.
doi:10.1093/rheumatology/39.12.1403
[7] A. A. Kalla and M. Tikly, “Rheumatoid Arthritis in the
Developing World,” Best Practice & Research Clinical
Rheumatology, Vol. 17, No. 5, 2003, pp. 863-875.
doi:10.1016/S1521-6942(03)00047-0
[8] S. Allaire, F. Wolfe, et al., “Contemporany Prevalence and
Incidence of Work Disability Associated with Rheuma-
toid Arthritis in US,” Arthritis Care & Research, Vol. 59,
No. 4, 2008, pp. 474-480. doi:10.1002/art.23538
[9] A. Young, J. Dixey, et al., “Which Patients Stop Working
Because of Rheumatoid Arthritis? Results of Five Years’
Follow Up in 732 Patients from the Early RA Study
(ERAS),” Annals of the Rheumatic Diseases, Vol. 61, No.
4, 2002, pp. 335-340. doi:10.1136/ard.61.4.335
[10] M. J. Plant and M. M. O’Sullivan, “What Factors Influ-
ence Functional Ability in Patients with Rheumatoid Ar-
thritis. Do They Alter over Time?” Rheumatology, Vol.
44, No. 9, 2005, pp. 1181-1185.
doi:10.1093/rheumatology/keh707
[11] K. Puolakka, H. Kautiainen, T. Möttönen, et al., “Predic-
tors of Productivity Loss in Early Rheumatoid Arthritis:
A 5-Year-Follow-Up Study,” Annals of the Rheumatic
Diseases, Vol. 64, No. 1, 2005, pp. 130-133.
doi:10.1136/ard.2003.019034
[12] T. K. Kvein, “Epidemiology of Disability in Rheumatoid
Arthritis,” Rheumatology, Vol. 41, No. 2, 2002, pp. 121-
123. doi:10.1093/rheumatology/41.2.121
[13] T. K. Kvien, T. Uhlig, et al., “Epidemiological Aspects of
Rheumatoid Arthritis: The Sex Ratio,” Annals of the New
York Academy of Sciences, Vol. 1069, 2006, pp. 212-222.
doi:10.1196/annals.1351.019
[14] M. Wallenius, J. F. Skomsvoll, et al., “Comparison of
Work Disability and Health-Related Quality of Life be-
tween Males and Females with Rheumatoid Arthritis be-
low the Age of 45 Years,” Scandinavian Journal of Rhe-
umatology, Vol. 38, No, 3, 2008, pp. 178-183.
doi:10.1080/03009740802400594
[15] A. Macedo, S. Oakley, et al., “An Examination of Work
Instability, Functional Impairment, Ant Disease Activity
in Employed Patients with Rheumatoid Arthritis,” The
Journal of Rheumatology, Vol. 36, No. 2, 2009, pp. 1-6.
doi:10.3899/jrheum.071001
[16] C. Han, J. Smolen, et al., “Comparision of Employability
Outcomes among Patients with Early or Long-Standing
Rheumatoid Arthritis,” Arthritis Care & Research, Vol.
59, No. 4, 2008, pp. 510-514. doi:10.1002/art.23541
[17] S. Lillegraven and T. K. Kvien, “Measuring Disability and
Quality of Life in Established Rheumatoid Arthritis,”
Best Practice & Research Clinical Rheumatology, Vol.
21, No. 5, 2007, pp. 827-840.
doi:10.1016/j.berh.2007.05.004
[18] P. Katz and A. Morris, “Subclinical Disability in Valued
Life Activities among Individuals with Rheumatoid Ar-
thritis,” Arthritis Care & Research, Vol. 59, No. 10, 2008,
pp. 1416-1423. doi:10.1002/art.24110
Copyright © 2012 SciRes. OJRA
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
To assess the occurrence and prognostic factors for the ability to maintain paid work in patients with rheumatoid arthritis (RA). Inception cohort of patients with RA recruited from rheumatology departments in nine NHS Hospital Trusts in England. All consecutive patients with RA of less than two years' duration, before any second line (disease modifying) drug treatment, and followed up for five years. Clinical, laboratory, and radiological assessments, and all treatments were recorded prospectively using a standardised format at presentation and yearly. Changes in, and loss of paid work by five years' follow up. 732 patients completed the five year follow up. 353/721 (49%) were gainfully employed at the onset of RA, 211 (60%) were still working at five years, 104 (29%) stopped because of the disease, and 31 (9%) retired for reasons other than RA. Work disability at five years was more likely in manual workers (odds ratio (OR) 2.3, 95% confidence interval (CI) 1.4 to 3.8) and worse baseline Health Assessment Questionnaire (HAQ>1.5, OR 2.26, 95% CI 1.38 to 3.7). In combination with other baseline variables (erythrocyte sedimentation rate, sex, age of onset, and radiological erosions), employment outcome was predicted in 78% using multivariate analysis. Nearly half of the patients with RA were in paid employment at onset, work disability was an adverse outcome for a third of these patients by five years, and manual work and high baseline HAQ were important predictors for this. These details are likely to be useful to clinicians, health professionals, and patients in order to plan medical, orthopaedic, and remedial treatments in early RA. Future disease modifying treatments could be compared with this cohort of patients who were treated with conventional second line drugs.
Article
To evaluate the relationship between the Disease Activity Score 28-joint count (DAS28), Health Assessment Questionnaire (HAQ), and Rheumatoid Arthritis-Work Instability Scale (RAWIS); and to define thresholds for clinical assessments associated with moderate to high RA-WIS. Employed patients with RA were evaluated using DAS28, HAQ, and RA-WIS during routine clinics. Relationships between these assessments were evaluated by simple correlation. Multiple linear regression modeling was performed using RA-WIS as an outcome variable and HAQ, DAS28, age, sex, occupation, and disease duration as input variables. Receiver-operating characteristic curves were then formulated to determine optimal DAS28, and HAQ cutoff points for RA-WIS >or= 10, along with the odds ratio (OR). Ninety patients with RA completed the RA-WIS, which was moderately correlated with DAS28 (r =0.53) and HAQ (r = 0.66). Fifty-four percent of RA-WIS was explained by DAS28 (p = 0.002), HAQ (p = 0.001), and sex (p = 0.04). A DAS28 of 3.81 and HAQ of 0.55 were clinically important thresholds. High DAS28 and HAQ were associated with high RA-WIS (OR(DAS) 14.17, OR(HAQ) 25.13, OR(DAS+HAQ) 29.9). Functional impairment and disease activity significantly and independently contributed to patient-perceived work instability risk.
Article
To compare work disability (WD) and health status between males and females with rheumatoid arthritis (RA) in the age group 18-45 years, and to compare health status between patients with and without WD within each gender, and finally to identify factors independently associated with WD in this age group. A cross-sectional study of RA patients at the time starting with disease-modifying antirheumatic drug (DMARD) therapy and/or biological treatment. Patients receiving a permanent, national WD pension corresponding to >or= 50% were defined as work disabled. We examined gender differences with regard to disease characteristics, health status and WD. The Mann-Whitney U-test and Pearson's chi(2)-test were applied for group comparisons. Multiple logistic regression analyses with adjustments for duration of education, disease duration, age, erosive disease, disability score [using the Modified Health Assessment Questionnaire (MHAQ)], Disease Activity Score-28 (DAS-28), the Short Form Health Survey (SF-36) mental health score and gender were used to identify variables associated with WD. Out of 474 (372 females) patients, the number (%) of work-disabled females/males was 91 (24.7)/8 (8.1) (p<0.001). WD was associated with worse health status in both genders. The odds ratio (95% confidence interval) [OR (95% CI)] for WD in females vs. males was 4.84 (1.85-12.65) in the multivariate analyses. Other factors independently associated with WD were worse mental health, disease duration and low level of education. Females with RA had a fourfold increased risk of WD compared to men. Low level of education, disease duration and worse mental health were also independently associated with WD.
Article
Subclinical disability, the need for modifications in task performance or frequency without reported difficulty with the task, has been identified as a stage along the disability continuum. We estimated the prevalence of subclinical disability in valued life activities (VLAs) among individuals with rheumatoid arthritis (RA), identified characteristics of individuals with VLA subclinical disability, and estimated the ability of VLA subclinical disability to predict later decrements in functioning. Data were from 3 years of a longitudinal panel study of individuals with RA, for which annual structured telephone interviews are conducted (n=508 in year 1, n=442 in year 3). Respondents rated difficulty in VLAs and then reported whether they used any of 4 behavioral modifications (limitations, extra time, help, or equipment) for each. Subclinical disability was defined for each VLA as no reported difficulty with use of any modification. Multiple regression analyses identified predictors of subclinical disability in year 1 and the role of year 1 subclinical disability in development of overt disability between year 1 and year 3. Almost three-quarters of the subjects exhibited subclinical disability in at least 1 VLA in year 1. Duration of RA was consistently associated with subclinical disability. Individuals with subclinical disability at baseline were significantly more likely to experience increases in functional limitations (odds ratio [OR] 1.09, 95% confidence interval [95% CI] 1.01-1.18) and VLA disability (OR 1.14, 95% CI 1.06-1.23) over a prospective 2-year period. Subclinical disability may be a valuable marker of individuals in a disability transition phase who are particularly susceptible to intervention that would enable them to maintain functioning.
Article
To assess the impact of rheumatoid arthritis (RA) on function and how this affects major aspects of patients' lives. The inception cohort of RA patients was recruited from rheumatology out-patient departments in nine National Health Service (NHS) hospital trusts in England. All consecutive patients with RA of less than 2 yr duration, prior to any second-line (disease-modifying) drug treatment were recruited and followed-up for 5 yr. Standard clinical, laboratory and radiological assessments, and all hospital-based interventions were recorded prospectively at presentation and yearly. The outcome measures were clinical remission and extra-articular features, functional ability [functional grades I-IV and Health Assessment Questionnaire (HAQ)], use of aids, appliances and home adaptations, orthopaedic interventions, and loss of paid work. A total of 732 patients completed 5 yr of follow-up, of whom 84% received second-line drugs. Sixty-nine (9.4%) had marked functional loss at presentation, compared with normal function in 243 (33%), and by 5 yr these numbers had increased in each group, respectively, to 113 (16%) and 296 (40%). Home adaptations and/or wheelchair use by 5 yr were seen in 74 (10%). Work disability was seen in 27% of those in paid employment at onset. One hundred and seventeen (17%) patients underwent orthopaedic surgery for RA, 55 (8%) for major joint replacements. Marked functional loss at 5 yr was more likely in women [odds ratio (OR) 1.63, 95% confidence interval (CI) 1.04-2.5], patients older than 60 yr (OR 1.94, 95% CI 1.3-2.9), and with HAQ > 1.0 at presentation (OR 4.4, 95% CI 2.8-7.0). Clinical profiles of RA patients treated with conventional drug therapy over 5 yr showed that a small proportion of patients (around 16%) do badly functionally and in terms of life events, whereas around 40% do relatively well. The details and exact figures of cumulative disability are likely to be useful to clinicians, health professionals and patients. The rate of progression and outcome in these patients can be compared against future therapies with any disease-modifying claims.
Article
To establish the prevalence of work disability and predictors of change in employment status in patients with early rheumatoid arthritis (RA). The Norfolk Arthritis Register (NOAR), a primary-care based inception cohort of patients with recent-onset inflammatory arthritis. Two cohorts of patients notified to NOAR, who satisfied the 1987 ACR criteria for RA at the time of notification (baseline) and who were economically active at the time of RA symptom onset, were identified. Cohort 1 consisted of 160 patients with an onset of RA between 1989 and 1992, and was followed for a mean of 8.6 yr from symptom onset. For 110 of these cases, a control group, matched for age, gender and employment status at baseline, was identified from the local population. Their employment histories were compared in 1995. Cohort 2 consisted of 134 patients with an onset of RA between 1994 and 1997, and was followed for a mean of 4.1 yr from symptom onset. One-third of RA cohort 1 had stopped working on the grounds of ill health by 1995. The baseline health assessment questionnaire (HAQ) score was the most important predictor of work disability. These patients were 32 times more likely to stop work on health grounds than the matched controls. The rates for work disability for the RA cases 1, 2, 5 and 10 yr after symptom onset were 14, 26, 33 and 39% respectively. For cohort 2, the rates for work disability 1 and 2 yr from onset were 23 and 33% respectively. Work disability is an important outcome in RA patients of working age. Many people stop working very early in the disease process, often before they are referred to hospital or started on disease-modifying anti-rheumatic drugs. Although the peak rates for work disability are in the early years, people with RA continue to leave the work force several years after onset. Thus, the recent move to earlier, more aggressive treatment has had no effect on the rates of work disability.
Article
Two recent studies suggest the prevalence of rheumatic condition-related work disability is considerably lower than was suggested in previous studies. However, the samples in the recent studies did not include older workers and included persons who gained employment after disease onset. In other recent studies, the rate of work disability among persons employed at disease onset is still high; a fair amount of work disability occurs in the early years of disease. There is no clear evidence yet that treatment improvements have altered the rates of work disability. Because work characteristics, like level of physical demand, influence risk for work disability and are potentially amenable, other interventions are needed to reduce rheumatic disease-associated work disability. Accommodation provided to alleviate problems in doing work and outside of work activities is the most promising intervention, followed by job/career change. Assessment tools are just now becoming available to help clinicians identify patients in need of assistance.
Article
The general impression is that rheumatoid arthritis (RA) has a lower prevalence and a milder course in developing countries. Epidemiological studies from different regions show that varying prevalence is possibly related to urbanization. The data suggest that where severe disability does occur, it presents a significant health challenge because of scarce medical and social resources. Disease-modifying anti-rheumatic drugs (DMARDs) remain the mainstay of therapy to alter the natural history of the disease. New therapies are unlikely to be of general benefit in the developing world because of financial constraints and increased risk of infections, particularly tuberculosis, associated with the use of tumour necrosis factor-alpha blockers. Instead, future research in poorer communities should be directed at assessing the burden of disease, the role of early aggressive therapy with DMARDs in combination with glucocorticoids for the majority of patients with RA, and finally, sourcing targeted biological therapies through clinical trials and grants for compassionate use in patients with refractory disease.
Article
Rheumatoid arthritis (RA) causes disability, deformities, progressive radiological joint damage often with a need for joint replacement surgery, premature death, and alterations in quality of life. The economic burden created by RA is enormous. Direct costs per patient have been estimated at 1812-11,792 Euro annually and indirect costs at 1260-37,994 Euro annually. These mean values are approximations, as variations occur across countries, healthcare system organizations, and geographic locations. Direct costs account for one-fourth to slightly over a half of the total cost. Costs associated with inpatient care contribute up to 75% of direct costs, as compared to only about 20% for medications, although wide variations occur in costs related to drug monitoring and side-effect management. Physician visits account for about 20% of direct costs. As compared to indirect health costs for individuals from the general population, those for RA patients are increasing at a rapid rate. Indirect costs account for 80% of the excess cost related to RA. Cost estimates may change over time and show huge variations across individuals, with a small minority of patients accounting for most of the costs. Disability as measured by the Health Assessment Questionnaire (HAQ) has a major impact on costs. Early effective treatment may not only postpone and slow disease progression, thereby improving quality of life, but also decrease costs by preserving productivity and reducing the need for surgery, admission to acute-care and extended-care hospitals, and social service utilization. Data are beginning to accumulate on the excess costs associated with biotherapies and other new second-line drugs. They indicate acceptable excess costs relative to the additional medical benefits and to the cost-effectiveness of other healthcare programs. Nevertheless, the threshold that defines an acceptable excess cost is arbitrary and varies with local economic conditions.